Synopsis
The Covid drug portfolio grew 8% in value while the value growth of non-Covid drugs stood at 21%. “The Covid drugs growth has come down and is in line with the seasonal disease demand generation”, said Sheetal Sapale, president-marketing, AWACS.
ET Intelligence Group: After three consecutive months of posting a negative rate of relative growth, thanks to the high base effect of the second Covid wave, the Indian pharma market posted an exceptional growth of 16% for the month of June as per data released by AWACS. However, overall, on a quarterly basis, the June quarter has posted a 2% expansion against the 37.7% growth posted in the same quarter last year.
The months of April and May
- FONT SIZE
AbcSmall
AbcMedium
AbcLarge
Why ?
![]()
Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors
![]()
Stock analysis. Market Research. Industry Trends on 4000+ Stocks
![]()
Clean experience with
Minimal Ads![]()
Comment & Engage with ET Prime community ![]()
Exclusive invites to Virtual Events with Industry Leaders ![]()
A trusted team of Journalists & Analysts who can best filter signal from noise
